Key result
Female sex linked to ~37% higher in-hospital mortality in patients with PAD and sarcopenia.
Why the study?
Do clinical characteristics, therapies, and in-hospital outcomes differ between female and male patients hospitalized with peripheral artery disease and sarcopenia?
Observational (n=3,282)
Yes
Do clinical characteristics, therapies, and in-hospital outcomes differ between female and male patients hospitalized with peripheral artery disease and sarcopenia?
Answers are grounded in this paper and cite their sources.
Among hospitalized patients with PAD and sarcopenia, females experience higher in-hospital mortality, while males undergo more frequent amputations and surgical revascularizations.
Introduction In patients with peripheral artery disease (PAD), sarcopenia represents a relevant risk factor for morbidity and mortality. Still, sarcopenia is a widely underrecognized and underestimated comorbidity in patients with PAD. Purpose Aim of the present study was to investigate the sex-specific differences in female and male sarcopenic PAD patients regarding patient-characteristics, clinical course, therapy and outcome of hospitalized patients with PAD. Methods The German nationwide inpatient statistics was analyzed (source: RDC of the Federal Statistical Office and the Statistical Offices of the federal states, DRG Statistics 2005-2020, and own calculations). All hospitalization cases due to PAD with additional coding for sarcopenia in Germany within the years 2005-2020 were included and stratified for patients’ sex. Differences between female and male sarcopenic PAD patients were analysed. Results During the observational period between 2005 and 2020 in Germany a total of 3282 hospitalization cases due to PAD with additional coding for sarcopenia was counted. Median age of all patients was 78.0 (IQR 71.0-84.0) years, the median Charlson Comorbidity Index score was 6.0 (4.0-8.0) and the median length of in-hospital stay was 20.0 (IQR 12.0-30.0) days. Sarcopenic patient-cases were more likely of male sex (n= 1821; 55.5%) in comparison to female patient-cases (n= 1461; 44.5%). Female patients with PAD and sarcopenia were older (81.0 [75.0-87.0] vs. 76.0 [68.0-82.0] years, P<0.001) and had more comorbidities as seen by a higher Charlson Comorbidity Index (7.0 [5.0-8.0] vs. 6.0 [3.0-8.0], P<0.001). Surgical revascularization of the lower extremities was more often performed in males (17.0% vs. 14.0%, P=0.018), whereas interventional revascularization of the lower extremities was similarly used in both sexes (12.7% vs. 11.8%, P=0.429). In male PAD patients with sarcopenia amputation rates were higher than in female patients (27.2% vs. 21.7%, P<0.001). Contrary, in female patients higher in-hospital case-fatality rates were detected compared to male patients (8.9% vs. 6.5%, P=0.009). Also, MACCE rates showed a trend towards higher occurrence in female compared to male sarcopenic PAD patients (11.0% vs. 9.1%, P=0.070). Conclusion In hospitalized patients with PAD and sarcopenia significant sex-specific differences were detected concerning patient profile, therapy strategy, performance of amputation, and mortality. Further studies are essential to elucidate the reasons of sex-specific differences in sarcopenic PAD patients.
No takes yet. Share an insight, caveat, or question.
Schmitt et al. (2025) conducted an observational in Peripheral artery disease and sarcopenia (n=3,282). Female sex vs. Male sex was evaluated on In-hospital case-fatality (p=0.009). Among hospitalized patients with peripheral artery disease and sarcopenia, female sex was associated with higher in-hospital case-fatality compared to male sex.
Synapse has enriched 10 related papers. Consider them for comparative context: